Greenwich LifeSciences, Inc. (GLSI) NASDAQ

10.70

-0.57(-5.06%)

Updated at December 12 03:59PM

Currency In USD

Valuation

Market Cap146.15M
Enterprise Value142.06M
P/E Ratio-7.49
PEG Ratio1.02
Price/Sales Ratio41,009.43
Price/Book Ratio66.8
Enterprise/Revenue39,955.45
Enterprise/EBITDA-7.39

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-5,391.94
Operating Margin-5,422.78

Management Effectiveness

Return On Assets-5.12
Return On Equity-10.43

Income Statement

Revenue0
Revenue/Share0
Gross Profit-3,612
EBITDA-15.79M
Net Income-15.79M
Diluted EPS-1.21

Balance Sheet

Total Cash3.81M
Total Cash/Share0.28
Total Debt0
Total Debt/Equity0
Current Ratio2.35
Book Value Per Share0.16

Price History

52-Week Change-17.05
52-Week High14.47
52-Week Low7.78
Moving Average 50 Days9.25
Moving Average 200 Days10.24

Statistics

Average Volume99,423.1
Shares Outstanding13.84M
% Held by Institutions9.08

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A